FDA proposes health warning for feminine sprays
The FDA proposed labeling requirements for feminine deodorant sprays in a move to curb health risks. It found no medicinal or hygienic value, citing 174 adverse reports since 1967, though it stopped short of removing products. Industry spokesmen pledged compliance while defending the products.
MENTIONED IN THIS ARTICLE
FDA
Washington
Johnson & Johnson
Bristol Myers
Ferinique
Eight comprehensive cancer centers created in U.S. war on cancer
The government announced eight new comprehensive cancer centers under a $500 million annual effort to accelerate cancer research and patient access. Centers include Johns Hopkins in Baltimore Duke Durham University Alabama Birmingham Wisconsin Madison Fred Hutchinson Seattle USC Los Angeles County Miami University of Miami Medical School.
MENTIONED IN THIS ARTICLE
Washington
Frank Rauscher
National Cancer Institute
Rauscher
Senate
Children's Cancer Research Foundation
Boston
The
Johns
Also Mentioned on This Page
Federal Trade Commission
Alberto Culver Uo
Stephen Bray
Warner- Lambert
Pristeen
U.S
Aaron Schultz
AJOR
Munown
LEES
Bigrilow
Couristan
Firth, Walters
Hollytex
Wanda Weve
Coronet
OZITE
REGAL
Gal Jesses
California
Home Fashion
Garden Court
Atlantic Avenue
Long Beach
San Diego
Artesia
Leland Ley
Compleix Perrondl Security
Son City Civic Au
Weaten Bnet Ant
Toa Ae
Sun City Gardens
Tasdo Bradley
Lakewood Blvd
Lakewood Center
Euclid
Anaheim
Huntington Center
Huntington Beach